Joshua C Snyder

12PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersGlycoconjugatesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2026
P95-HER2 promotes metastatic progression by biasing MRTFA dependent signaling.

|May 27, 2026
β-Arrestin condensates regulate G-protein-coupled receptor function.

|Mar 19, 2025
Nonlinear progression during the occult transition establishes cancer lethality.

Joshua D Ginzel, Henry Chapman, Joelle E Sills

|Feb 20, 2025
Adaptive selection of p53 mutation metaplastic phenotypes in estrogen-independent progression of ER+ tumors: A mechanism for acquired resistance to hormonal therapy.

Hyeongsun Moon, Hidetoshi Mori, Jane Chen

|Oct 09, 2024
Precision preclinical modeling to advance cancer treatment.

David H Gutmann, Jesse S Boehm, Elinor K Karlsson

|May 07, 2024
Nonlinear progression during the occult transition establishes cancer lethality.

Joshua D Ginzel, Henry Chapman, Joelle E Sills

Pageof 2

Frequent Collaborators

7 joint publications

Herbert Kim Lyerly

5 joint publications

Joshua D Ginzel

3 joint publications

Zachary C Hartman

3 joint publications

Alexander D Borowsky